Gossamer Bio, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
D. E. Shaw entities have filed an amendment to their Schedule 13D, reporting a combined beneficial ownership of 7.1% of Gossamer Bio, Inc. common stock.
NASDAQ
D.E. Shaw entities report transactions in Gossamer Bio common stock over the past 60 days, with significant net sales.
NASDAQ
D. E. Shaw & Co. reports a 9.5% beneficial ownership stake in Gossamer Bio following a debt-for-equity exchange offer.
NASDAQ
Growth Equity Opportunities 18 VGE, LLC and affiliated entities have significantly reduced their beneficial ownership in Gossamer Bio, Inc. through recent open market sales.